Clinical trial
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
NCT01589978 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- June 30, 2018
- Enrollment
- 2,681 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.